DGAT1, ABHD5, and ATGL are overexpressed in prostate cancer cells compared to peripheral blood mononuclear cells, and inhibition of DGAT1 and ABHD5 was found to lead to prostate cancer cell death (107). This evidence concerns the gene ABHD5 and prostate carcinoma.